On 29 April 2026, 3SBio Inc. (三生制药) issued a reminder to all registered shareholders that the company has fully adopted electronic dissemination for future corporate communications, following its initial notice dated 6 March 2024.
The scope of “Corporate Communications” covers key shareholder documents, including annual and interim reports (and related financial summaries), notices of meeting, listing documents, circulars and proxy forms. Both English and Chinese versions of these materials will be accessible on the company’s website (www.3sbio.com) and the HKEXnews platform (www.hkexnews.hk). Printed copies will no longer be distributed as standard practice.
3SBio is actively soliciting shareholders’ email addresses to ensure timely delivery of publication alerts. Investors can provide their contact details by scanning a personalized QR code on the enclosed reply form or by returning the signed form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai.
Shareholders who do not supply a functional email address will not receive publication notifications and must independently monitor the company’s and HKEXnews websites for updates. In such cases, any actionable corporate communications—documents requiring shareholder instructions—will continue to be dispatched in printed form.
Investors preferring hard-copy materials for all future corporate communications may request printed versions by returning the reply form or emailing 3sbio.ecom@computershare.com.hk. This preference remains valid for one year from the date the instruction is received.
For further enquiries, shareholders can contact the share registrar on (852) 2862 8688 during business hours, Monday to Friday (excluding Hong Kong public holidays).
Comments